Research & Development
BioWave Corporation unveils non-opioid, over-the-counter pain relief technology BioWaveGO
9 January 2019 -

Health technology company BioWave Corp reported on Tuesday the availability of the new US FDA cleared, over the counter version of its popular, non-opioid, patented, pain relief technology, the BioWaveGO.

The company said the BioWave products are Professional Athlete proven and US Military trusted and is currently used by most NFL, NBA, NHL, and MLB teams, 160+ college programmes, over 80 VA hospitals, as well as by pain doctors nationally.

BioWave is available in a wearable, non-prescription strength to help anyone in acute or chronic pain lead a fuller and active pain-free life. BioWave technology has been proven effective, significantly reducing pain from just one 30-minute treatment and comes with a 30-day money back guarantee. The US FDA-cleared, high-frequency neurostimulation technology delivers soothing therapeutic signals through the skin into deep tissue, blocking pain signals at the source, added the company.

In conjunction, the company stated the development of the new BioWaveGO OTC product is the natural evolution of a patented neurostimulator pain relief technology that was developed over more than ten years. BioWaveGo is available for purchase on the BioWave website and under Federal Supply Schedule contract number V797D-70205.



Related Headlines